More threads by Halo


Abbott gets FDA approval to sell arthritis drug for Crohn's disease
The Boston Globe

WASHINGTON -- Abbott Laboratories won US approval to market the arthritis drug Humira to treat adults who have the bowel disorder Crohn's disease.

The Food and Drug Administration gave notice of the approval in an e-mail yesterday. Crohn's is the first nonarthritis use for the drug.

Humira, Abbott's top-selling product with $2 billion in sales last year, is already approved for rheumatoid arthritis, psoriatic arthritis, and spinal arthritis. The new approval may generate $400 million to $500 million in additional sales, said an Abbott spokeswoman. Humira competes with Johnson & Johnson's Remicade, approved in 1998 for treating Crohn's.

Unlike Remicade, which requires a doctor's office or infusion center visit for treatment, Humira is self-injected twice a month with a pen-like device.

Crohn's affects about 600,000 Americans.


One of my brothers has Crohns, I haven't talked to him in 7 years but the last I knew there wasn't anything else the docs could do for him if it flared up again...He's been on/off Prednisone for years....This is interesting, thanks Halo!....RIMH
Last edited by a moderator:
Replying is not possible. This forum is only available as an archive.